Newsroom

  • Category

  • By Date

  • Press Release

    13 December 24

    CuraTeQ Biologics receives CHMP positive opinion for Filgrastim biosimilar

    Read more
  • Press Release

    12 November 24

    EMA grants GMP certificate to CuraTeQ Biologics’ manufacturing facility in Hyderabad

    Read more
  • Press Release

    15 March 24

    CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar

    Read more